See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2019_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 273,870 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,418 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 315,006 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,178,087 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,325,519 |
| 9 | ResearchAndDevelopmentExpense | 101,697 |
| 10 | remainder_Expenses | -16,844 |
| 11 | remainder_Revenues | 70,356 |
| 12 | remainder_NetIncome | -266,312 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 281,040 |
| 1 | Liabilities | 2,493,093 |
| 2 | Expenses | 1,410,372 |
| 3 | Revenues | 70,356 |
| 4 | StockholdersEquity | -2,212,053 |
| 5 | NetIncome | -1,606,328 |
| 6 | ComprehensiveNetIncome | -1,606,328 |
| 7 | BaseVar | 2,260,586 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.63 |
| 9 | EconomicCapitalRatio | 0.253 |
Edgar->Model Mapping
Feature Distribution
Change over Time
